492 reports of this reaction
1.9% of all BREXPIPRAZOLE reports
#11 most reported adverse reaction
PRODUCT USE ISSUE is the #11 most commonly reported adverse reaction for BREXPIPRAZOLE, manufactured by Otsuka America Pharmaceutical, Inc.. There are 492 FDA adverse event reports linking BREXPIPRAZOLE to PRODUCT USE ISSUE. This represents approximately 1.9% of all 26,345 adverse event reports for this drug.
Patients taking BREXPIPRAZOLE who experience product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT USE ISSUE is a less commonly reported adverse event for BREXPIPRAZOLE, but still significant enough to appear in the safety profile.
In addition to product use issue, the following adverse reactions have been reported for BREXPIPRAZOLE:
The following drugs have also been linked to product use issue in FDA adverse event reports:
PRODUCT USE ISSUE has been reported as an adverse event in 492 FDA reports for BREXPIPRAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT USE ISSUE accounts for approximately 1.9% of all adverse event reports for BREXPIPRAZOLE, making it a notable side effect.
If you experience product use issue while taking BREXPIPRAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.